Introduction:
Chronic hemodialysis is a kidney replacement therapy that potentially impairs patients' quality of life and leads to psychic disorders. The aim of this study was to determine the prevalence and the factors associated with anxiodepressive states in chronic hemodialysis patients in our center.
Methods:
This was a descriptive and analytical cross-sectional study conducted in our hemodialysis center during the period from May 15 to June 15, 2023. We included all chronic hemodialysis patients at the center who had given their informed consent to participate in this study. Patients admitted for acute dialysis and those undergoing transient hemodialysis in our center were excluded. Data were collected using an elaborate questionnaire including sociodemographic characteristics, clinical informations and the modified Hamilton Anxiety and Depression Scale. Data were analyzed using R 4.3.2 software. Chi-square and Fisher tests were used, with an alpha risk of 5%.
Results:
A total of 54 patients were included, with a mean age of 47.26 ± 14.72 years, extremes of 20 and 75 years, and a male predominance (53.7%). Undetermined nephropathy (N=24) was the most frequent cause of chronic end-stage renal disease. The mean duration of hemodialysis was 46.6 ± 0.26 months. Anxiety and depressive state were definite in 28 (51.9%) patients and doubtful in 8 (14.8%). The definite state of anxiety was statically associated with the duration of the disease, economic situation over the previous six months and promiscuity (p-value < 0.05).
Conclusions:
Anxiety and depressive state are a reality in chronic hemodialysis patients. Appropriate management of these patients requires a multidisciplinary approach involving nephrologists and psychiatrists.
I have no potential conflict of interest to disclose.
I did not use generative AI and AI-assisted technologies in the writing process.